The funniest thing I heard in the webcast was when a question was raised ‘about leaving the Nasdaq’ GC was flabbergasted and didn’t understand stand the question at first , then said ‘why would you do that’ . LOL
My opinion is they already have a date which will coincide with Brazil trial ending and market closing for Christmas, and then open on main market with news of efficacy in Brazil. Well that’s what I’d do. GLA
That’s a hard one, Tils have got the unlimited potential with there drugs or Accustem has expertly trialed product with results of 50% better than the best. Don’t know Bluebelly but I’m glad I’m in both.
Brazil has got to be the pivotal moment. But Hey will still have Accustem, MS trial apparently started, Alzheimer’s trial,and don’t forget Interlukin 6 trial , started in monkeys ,and humans in Jan21